Skip Navigation



NDT Advance Access published online on May 16, 2006
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfl246
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/7/1752    most recent
gfl246v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Walz, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walz, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Editorial Comment

Therapeutic approaches in autosomal dominant polycystic kidney disease (ADPKD): is there light at the end of the tunnel?

Gerd Walz 1 *

1 Renal Division, Freiburg, Germany

* To whom correspondence should be addressed.
Gerd Walz, E-mail: gerd.walz{at}uniklinik-freiburg.de



This article has no Abstract. Keywords: mTOR inhibitors; polycystic kidney disease; tacrolimus; vasopressin-2 receptor antagonist.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
D.-C. Fischer, U. Jacoby, L. Pape, C. J. Ward, E. Kuwertz-Broeking, C. Renken, H. Nizze, U. Querfeld, B. Rudolph, D. E. Mueller-Wiefel, et al.
Activation of the AKT/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD)
Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1819 - 1827.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
T. A. Natoli, T. C. Gareski, W. R. Dackowski, L. Smith, N. O. Bukanov, R. J. Russo, H. Husson, D. Matthews, P. Piepenhagen, and O. Ibraghimov-Beskrovnaya
Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F73 - F83.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
O. Ibraghimov-Beskrovnaya
Molecular pathogenesis of ADPKD and development of targeted therapeutic options
Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3367 - 3370.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
E. W. Kuehn and G. Walz
Prime time for polycystic kidney disease: does one shot of roscovitine bring the cure?
Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2133 - 2135.
[Full Text] [PDF]

Home page
 CJASNHome page
A. Schwarz, S. Vatandaslar, S. Merkel, and H. Haller
Renal Cell Carcinoma in Transplant Recipients with Acquired Cystic Kidney Disease
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 750 - 756.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Renin-Angiotensin-Aldosterone SystemHome page
C. R Lawson, T. W Doulton, and G. A MacGregor
Review: Autosomal Dominant Polycystic Kidney Disease: Role of the Renin-Angiotensin System in Raised Blood Pressure in Progression of Renal and Cardiovascular Disease
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2006; 7(3): 139 - 145.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.